|
Re: Tamoxifen, LHRH agonist, AI, oophorectomy??
I really appreciate these thoughtful responses! I should stress that I am not triple positive but ER+/PR-, and one study found that the PR- part was predictive of Tamoxifen resistance. My onc is also quite skeptical of the CYP2D6 test.
Best,
Jane
__________________
diagnosed Oct. 2011, age 49, 0.7 cm., node negative, stage 1, grade 3, her2+/ER+/PR-
right mast Nov. 2011
6 rounds TCH chemo started Dec. 16, 2011
|